Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doris Kaltenecker

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Nature Communications|February 20, 2025
Fc-engineered large molecules targeting blood-brain barrier transferrin receptor and CD98hc have distinct central nervous system and peripheral biodistributionNathalie Khoury, Michelle E Pizzo, Claire B Discenza, et al.
Nature Communications|April 15, 2026
Author Correction: Fc-engineered large molecules targeting blood-brain barrier transferrin receptor and CD98hc have distinct central nervous system and peripheral biodistributionNathalie Khoury, Michelle E Pizzo, Claire B Discenza, et al.
Nature|May 20, 2026
A deep-learning framework reveals whole-body perturbations at cell levelDoris Kaltenecker, Izabela Horvath, Rami Al-Maskari, et al.
Cell|August 10, 2023
Distinct molecular profiles of skull bone marrow in health and neurological disordersZeynep Ilgin Kolabas, Louis B Kuemmerle, Robert Perneczky, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Nature Communications|February 20, 2025
Fc-engineered large molecules targeting blood-brain barrier transferrin receptor and CD98hc have distinct central nervous system and peripheral biodistributionNathalie Khoury, Michelle E Pizzo, Claire B Discenza, et al.
Nature Communications|April 15, 2026
Author Correction: Fc-engineered large molecules targeting blood-brain barrier transferrin receptor and CD98hc have distinct central nervous system and peripheral biodistributionNathalie Khoury, Michelle E Pizzo, Claire B Discenza, et al.
Nature|May 20, 2026
A deep-learning framework reveals whole-body perturbations at cell levelDoris Kaltenecker, Izabela Horvath, Rami Al-Maskari, et al.
Cell|August 10, 2023
Distinct molecular profiles of skull bone marrow in health and neurological disordersZeynep Ilgin Kolabas, Louis B Kuemmerle, Robert Perneczky, et al.
Pageof 3